Literature DB >> 32841891

Treatment use among children with Tourette syndrome living in the United States, 2014.

Sara Beth Wolicki1, Rebecca H Bitsko2, Joseph R Holbrook3, Melissa L Danielson3, Benjamin Zablotsky4, Lawrence Scahill5, John T Walkup6, Douglas W Woods7, Jonathan W Mink8.   

Abstract

Treatment of Tourette syndrome (TS) can be complicated by changes over time in tic expression, severity, and co-occurring disorders. Using the 2014 National Survey of the Diagnosis and Treatment of ADHD and Tourette Syndrome, this study provides descriptive estimates of the use of behavioral interventions and medication among children living with TS. Parent-reported data on 115 children aged 5-17 years ever diagnosed with TS were analyzed to provide descriptive, unweighted results. Overall, 77.4% of children had current or past use of any TS treatment; 59.1% ever used behavioral interventions and 56.1% had ever taken TS medication. Children with "moderate" or "severe" versus "mild" TS, ≥1 co-occurring disorders, and tics that interfered with functioning were significantly more likely to have used one or more TS treatments. Side effects were reported for 84.4% of children who took TS medication. Most parents of children with current TS (87.2%) were satisfied with the management of their child's TS. However, parents of children with "moderate" or "severe" current TS were significantly more dissatisfied compared to parents of children with "mild" TS. Findings from this study could be used to inform efforts to support children living with TS and their families.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Adolescents; Behavior therapy; Medication; Movement disorders; Neurodevelopmental disorders; Public health; Tic Disorders

Mesh:

Year:  2020        PMID: 32841891      PMCID: PMC7669536          DOI: 10.1016/j.psychres.2020.113400

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  28 in total

1.  Tourette Syndrome has Substantial Impact in Childhood and Adulthood As Well.

Authors:  Irene Malaty; Diana Shineman; Michael Himle
Journal:  J Dev Behav Pediatr       Date:  2019 Jul/Aug       Impact factor: 2.225

2.  Course of Tourette Syndrome and Comorbidities in a Large Prospective Clinical Study.

Authors:  Camilla Groth; Nanette Mol Debes; Charlotte Ulrikka Rask; Theis Lange; Liselotte Skov
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2017-02-02       Impact factor: 8.829

3.  The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009.

Authors:  Tamara Pringsheim; Darren Lam; Scott B Patten
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12-02       Impact factor: 2.576

4.  Design and Operation of the National Survey of Children's Health, 2011-2012.

Authors:  Matthew D Bramlett; Stephen J Blumberg; Benjamin Zablotsky; Jacquelyn M George; A Elizabeth Ormson; Alicia M Frasier; Danielle M Vstecka; Kim L Williams; Benjamin J Skalland; Heather M Morrison; Kathleen B Santos; Steven Pedlow; Fang Wang
Journal:  Vital Health Stat 1       Date:  2017-07

5.  Children with Tourette Syndrome in the United States: Parent-Reported Diagnosis, Co-Occurring Disorders, Severity, and Influence of Activities on Tics.

Authors:  Sara Beth Wolicki; Rebecca H Bitsko; Melissa L Danielson; Joseph R Holbrook; Benjamin Zablotsky; John T Walkup; Douglas W Woods; Jonathan W Mink
Journal:  J Dev Behav Pediatr       Date:  2019 Jul/Aug       Impact factor: 2.225

6.  The Differential Impact of Tourette's Syndrome and Comorbid Diagnosis on the Quality of Life and Functioning of Diagnosed Children and Adolescents.

Authors:  Deirdre O'Hare; Edward Helmes; John Reece; Valsamma Eapen; Kerry McBain
Journal:  J Child Adolesc Psychiatr Nurs       Date:  2016-03-16

Review 7.  Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

Authors:  Stefan Leucht; Andrea Cipriani; Loukia Spineli; Dimitris Mavridis; Deniz Orey; Franziska Richter; Myrto Samara; Corrado Barbui; Rolf R Engel; John R Geddes; Werner Kissling; Marko Paul Stapf; Bettina Lässig; Georgia Salanti; John M Davis
Journal:  Lancet       Date:  2013-06-27       Impact factor: 79.321

Review 8.  Clinical course of Tourette syndrome.

Authors:  Michael H Bloch; James F Leckman
Journal:  J Psychosom Res       Date:  2009-12       Impact factor: 3.006

9.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

Review 10.  Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome.

Authors:  Julio Quezada; Keith A Coffman
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.